Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.

Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, Revicki D, Buchanan RW.

Arch Gen Psychiatry. 2002 Nov;59(11):1021-6.

PMID:
12418935
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Risperidone side effects.

Conley RR.

J Clin Psychiatry. 2000;61 Suppl 8:20-3; discussion 24-5. Review.

PMID:
10811239
5.

Effectiveness and cost of risperidone and olanzapine for schizophrenia: a systematic review.

Hargreaves WA, Gibson PJ.

CNS Drugs. 2005;19(5):393-410. Review. Erratum in: CNS Drugs. 2005;19(9):784. Gibson, Joseph P [corrected to Gibson, P Joseph].

PMID:
15907151
6.

Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.

Aubry JM, Simon AE, Bertschy G.

J Clin Psychiatry. 2000 Sep;61(9):649-55. Review.

PMID:
11030485
7.

Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.

Kasper S.

Int Clin Psychopharmacol. 1998 Nov;13(6):253-62. Review.

PMID:
9861575
8.

Adverse events related to olanzapine.

Conley RR, Meltzer HY.

J Clin Psychiatry. 2000;61 Suppl 8:26-9; discussion 30. Review.

PMID:
10811240
9.

Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.

Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.

W V Med J. 2002 Mar-Apr;98(2):63-5. Review.

PMID:
12048741
10.

The routine use of atypical antipsychotic agents: maintenance treatment.

Kinon BJ.

J Clin Psychiatry. 1998;59 Suppl 19:18-22. Review.

PMID:
9847048
11.

Priapism associated with conventional and atypical antipsychotic medications: a review.

Compton MT, Miller AH.

J Clin Psychiatry. 2001 May;62(5):362-6. Review.

PMID:
11411819
12.

Use of olanzapine for elderly patients with psychotic disorders: a review.

Madhusoodanan S, Sinha S, Brenner R, Gupta S, Bogunovic O.

Ann Clin Psychiatry. 2001 Dec;13(4):201-13. Review.

PMID:
11958362
13.

[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

Briken P, Nika E, Krausz M, Naber D.

Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. Review. German.

PMID:
11880946
14.

Tardive dyskinesia in affective disorders.

Kane JM.

J Clin Psychiatry. 1999;60 Suppl 5:43-7; discussion 48-9. Review.

PMID:
10192407
15.

Olanzapine: a new atypical antipsychotic.

Littrell K, Peabody CD, Littrell SH.

J Psychosoc Nurs Ment Health Serv. 1996 Aug;34(8):41-6. Review. No abstract available.

PMID:
8856604
16.

Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.

Czekalla J, Kollack-Walker S, Beasley CM Jr.

J Clin Psychiatry. 2001;62 Suppl 2:35-40. Review.

PMID:
11232751
17.

New antipsychotic medications: strategies for evaluation and selected findings.

Schooler NR.

Schizophr Res. 1997 Oct 30;27(2-3):249-59. Review.

PMID:
9416654
18.

Common treatment goals of antipsychotics: acute treatment.

Sharif ZA.

J Clin Psychiatry. 1998;59 Suppl 19:5-8. Review.

PMID:
9847046
19.

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

Meyer JM, Koro CE.

Schizophr Res. 2004 Sep 1;70(1):1-17. Review.

PMID:
15246458
20.

Olanzapine in the long-term treatment of schizophrenia.

Kane J.

Br J Psychiatry Suppl. 1999;(37):26-9. Review.

PMID:
10211138
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk